WAND (wireless artifact-free neuromodulation device)
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
New Therapeutic Devices
Phase Of Development
Sponsors and Collaborators
Cortera Neurotechnologies, Inc
Mechanism of Action
Mechanism Description
closed loop electrodes (128 channels) - designed to be a pacemaker
Populations Tested In
n/a
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link